Novel Induction to Buprenorphine/Naloxone
Stopped early · Phase 4
Conditions studied: Opioid Use Disorder, Opioid Use, Opioid Abuse, Opioid Misuse, Opioid Dependence
In brief
Microdosing induction is a novel method of starting buprenorphine/naloxone without patients experiencing the opioid withdrawal that is a part of traditional induction. Patients take small doses of buprenorphine/naloxone that increase slowly over a week. Although microdosing induction has been supported anecdotally, its effectiveness is not known. The proposed study will compare the effectiveness and safety of two induction strategies for transitioning patients from opioids to buprenorphine/naloxone. All inductions will occur in an outpatient telehealth opioid use disorder (OUD) treatment setting. The study will compare patients who receive traditional induction versus microdosing induction. Primary outcomes include effectiveness and safety. Secondary outcomes include treatment retention, self-reported use of opioids during induction, return to opioid use, opioid appearance in drug screens, craving/withdrawal symptoms, and patient satisfaction.
Key facts
- Study ID
- NCT05644587
- Run by
- Bicycle Health
- People needed
- 33
- Starts
- 2023-02-06
- Expected to finish
- 2023-11-30
- Last updated by the study team
- 2024-08-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Enrollment with Bicycle Health services
- Aged 18 years old or older
- Diagnosis of opioid use disorder confirmed by DSM-5 criteria
- In no/mild withdrawal at the time of intake
- Need to undergo induction to buprenorphine from a full opioid agonist
- Use of full opioid agonists not directly from a pharmacy within the last 24 hours
- Pharmacy stock check of 2 mg film/tablet done before visit
- Willingness and ability to follow study protocols, and the ability to provide informed consent
You may not qualify if…
- Known allergy or sensitivity to buprenorphine/naloxone
- Any circumstance that precludes the need for induction
- In moderate to severe withdrawal at the time of intake
- Severe or complex medical/psychiatric comorbidity that requires a customized induction schedule or surveillance
- Any element that would exclude an individual from Bicycle Health services in general (e.g., homelessness, severe untreated mental illness)
- Patients requesting specific induction technique
- Patients who are pregnant or lactating
Where it is running
- Bicycle Health — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.